These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Comparison of conventional versus 24-hour blood pressure measurement. How often do variations in diagnostic/therapeutic evaluation occur?]. von Hoyningen-Huene K; Schmid R; Höfling B Fortschr Med; 1993 Nov; 111(32):501-4. PubMed ID: 8294074 [TBL] [Abstract][Full Text] [Related]
63. A comparative trial of timolol and flutonidin as antihypertensive agents. Salvadeo A; Segagni S; Villa G; Galli F; Piazza W; Bovio G Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):78-84. PubMed ID: 7037661 [TBL] [Abstract][Full Text] [Related]
64. [Clinical experience with the blood pressure lowering effect of Disotat]. Goldberg S Dtsch Gesundheitsw; 1970 Jan; 25(2):67-71. PubMed ID: 5436886 [No Abstract] [Full Text] [Related]
65. What is next when the first blood pressure-lowering drug is not sufficient? Fuchs FD; Guerrero P; Gus M Expert Rev Cardiovasc Ther; 2007 May; 5(3):435-9. PubMed ID: 17489668 [TBL] [Abstract][Full Text] [Related]
66. The problem of treatment in mild hypertension. Peart WS Br J Clin Pharmacol; 1982 Jan; 13(1):87-90. PubMed ID: 7039649 [No Abstract] [Full Text] [Related]
67. [Treatment of mild arterial hypertension--a perennial open question]. Bar-Andziak E; Miśkiewicz Z Pol Arch Med Wewn; 1984 Feb; 71(2):109-18. PubMed ID: 6377251 [No Abstract] [Full Text] [Related]
68. [Clinical observations on the use of an antihypertensive drug (Compound 1003)]. De la Hoz Fabra J; San Millán JG Rev Clin Esp; 1966 Jan; 100(2):126-30. PubMed ID: 5906403 [No Abstract] [Full Text] [Related]
69. [Treatment of acute, severe hypertension assessed in a multicentre study. The effects of rest and furosemide and a randomized clinical trial of chlorpromazine, dihydralazine and diazoxide]. Nielsen PE; Krogsgaard A; McNair A; Hilden T Ugeskr Laeger; 1981 Jun; 143(23):1451-7. PubMed ID: 7025410 [No Abstract] [Full Text] [Related]
70. Debrisoquine sulphate--a new antihypertensive agent with minimal side-effects. Chen BT Singapore Med J; 1971 Apr; 12(2):106-9. PubMed ID: 4945291 [No Abstract] [Full Text] [Related]
73. The Hypertension Detection and Follow-up Program design, methods, and baseline characteristics and blood pressure response of the study population. Davis BR; Ford CE; Remington RD; Stamler R; Hawkins CM Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):11-28. PubMed ID: 3538177 [No Abstract] [Full Text] [Related]
74. Salt to lower blood pressure. Ndeti CS; Horrobin DF; Burstyn PG; Hopcraft MM N Engl J Med; 1972 Apr; 286(14):782-3. PubMed ID: 4554520 [No Abstract] [Full Text] [Related]
75. Hypertension in the elderly. Dall JL; Williams BO; Beard K Scott Med J; 1985 Oct; 30(4):206-7. PubMed ID: 3912988 [No Abstract] [Full Text] [Related]
76. Conflicting clinical trials and the uncertainty of treating mild hypertension. Toth PJ; Horwitz RI Am J Med; 1983 Sep; 75(3):482-8. PubMed ID: 6351610 [TBL] [Abstract][Full Text] [Related]
77. [Analysis of the results of experimentation with Guanoxan]. Champion FI; Lahon H Brux Med; 1965 Jun; 45(24):659-64. PubMed ID: 5835877 [No Abstract] [Full Text] [Related]
78. Implications of the Hypertension Detection and Follow-up Program. The Hypertension Detection and Follow-up Program Cooperative Group. Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):3-10. PubMed ID: 3538179 [No Abstract] [Full Text] [Related]
79. Clinicians' interpretation of the results and implications of the Hypertension Detection and Follow-up Program. Cressman MD; Gifford RW Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):89-97. PubMed ID: 3538182 [No Abstract] [Full Text] [Related]